Cargando…

The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety

BACKGROUND: The low cost of thiazolidinediones makes them a potentially valuable therapeutic option for the > 300 million economically disadvantaged persons worldwide with type 2 diabetes mellitus. Differential selectivity of thiazolidinediones for peroxisome proliferator-activated receptors in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leonard, Charles E., Brensinger, Colleen M., Dawwas, Ghadeer K., Deo, Rajat, Bilker, Warren B., Soprano, Samantha E., Dhopeshwarkar, Neil, Flory, James H., Bloomgarden, Zachary T., Gagne, Joshua J., Aquilante, Christina L., Kimmel, Stephen E., Hennessy, Sean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041286/ https://www.ncbi.nlm.nih.gov/pubmed/32098624 http://dx.doi.org/10.1186/s12933-020-00999-5

Ejemplares similares

Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations
por: Dhopeshwarkar, Neil, et al.
Publicado: (2020)

Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants
por: Leonard, Charles E., et al.
Publicado: (2022)

Type 2 Diabetes: Uses of thiazolidinediones and insulin
por: T. Bloomgarden, Zachary
Publicado: (2011)

Association Between Serious Hypoglycemia and Calcium-Channel Blockers Used Concomitantly With Insulin Secretagogues
por: Nam, Young Hee, et al.
Publicado: (2021)

Thromboembolic and neurologic sequelae of discontinuation of an antihyperlipidemic drug during ongoing warfarin therapy
por: Leonard, Charles E., et al.
Publicado: (2017)

Population-based screening to detect benzodiazepine drug-drug-drug interaction signals associated with unintentional traumatic injury
por: Chen, Cheng, et al.
Publicado: (2022)

Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less
por: Flory, James H, et al.
Publicado: (2021)

Rosiglitazone and Pioglitazone Alter Aromatase Kinetic Properties in Human Granulosa Cells
por: Araki, Takako, et al.
Publicado: (2011)

Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings
por: Niyomnaitham, Suvimol, et al.
Publicado: (2014)

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study
por: Juurlink, David N, et al.
Publicado: (2009)

Assessment of Physician Prescribing of Muscle Relaxants in the United States, 2005-2016
por: Soprano, Samantha E., et al.
Publicado: (2020)

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
por: Colhoun, H. M., et al.
Publicado: (2012)

Antidepressant-Warfarin Interaction and Associated Gastrointestinal Bleeding Risk in a Case-Control Study
por: Schelleman, Hedi, et al.
Publicado: (2011)

Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies
por: Deeg, Mark A., et al.
Publicado: (2008)

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
por: Berthet, Stephanie, et al.
Publicado: (2011)

Influence of health warnings on the use of rosiglitazone and pioglitazone in an area of Spain: A time-series study
por: Carracedo-Martínez, Eduardo, et al.
Publicado: (2016)

Development of Heart Failure in Medicaid Patients with Type 2 Diabetes Treated with Pioglitazone, Rosiglitazone, or Metformin
por: Breunig, Ian M., et al.
Publicado: (2014)

Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats
por: Rao, Ravi Prakash, et al.
Publicado: (2011)

Variation at the NFATC2 Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study
por: Bailey, Swneke D., et al.
Publicado: (2010)

Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated With Five Risk-Warning Events
por: Starner, Catherine I., et al.
Publicado: (2008)

Thiazolidinediones: the Forgotten Diabetes Medications
por: Lebovitz, Harold E.
Publicado: (2019)

Utilization and Costs for Compliant Patients Initiating Therapy With Pioglitazone or Rosiglitazone Versus Insulin in a Medicaid Fee-for-Service Population
por: Kalsekar, Iftekhar, et al.
Publicado: (2006)

Influence of SLCO1B1 and CYP2C8 gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers
por: Aquilante, Christina L, et al.
Publicado: (2008)

Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study
por: Nam, Young Hee, et al.
Publicado: (2018)

Correction: Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study
por: Nam, Young Hee, et al.
Publicado: (2018)

The quality of Medicaid and Medicare data obtained from CMS and its contractors: implications for pharmacoepidemiology
por: Leonard, Charles E., et al.
Publicado: (2017)

Comments on the article “Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study”
por: Thai, Thuy Nhu, et al.
Publicado: (2018)

Editorial: The role of sex in cardiac arrhythmias and sudden cardiac death
por: Pollevick, Matias E., et al.
Publicado: (2023)

Unmasking Differential Effects of Rosiglitazone and Pioglitazone in the Combination Treatment with n-3 Fatty Acids in Mice Fed a High-Fat Diet
por: Kus, Vladimir, et al.
Publicado: (2011)

Chemotherapy and Chemoprevention by Thiazolidinediones
por: Fröhlich, Eleonore, et al.
Publicado: (2015)

Thiazolidinediones and bone fractures
por: Kaku, Kohei, et al.
Publicado: (2011)

Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
por: Horita, Shoko, et al.
Publicado: (2015)

Autonomic neuropathy predisposes to rosiglitazone-induced vascular leakage in insulin-treated patients with type 2 diabetes: a randomised, controlled trial on thiazolidinedione-induced vascular leakage
por: Rennings, A. J., et al.
Publicado: (2010)

Thiazolidinediones are partially effective bitter blockers
por: Nguyen, Ha, et al.
Publicado: (2023)

Transgenic models of cardiac arrhythmias and sudden death
por: Remme, Carol Ann
Publicado: (2013)

Artificial Intelligence in Ventricular Arrhythmias and Sudden Death
por: Holmström, Lauri, et al.
Publicado: (2023)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists
por: Dawwas, Ghadeer K., et al.
Publicado: (2018)

Ryanodine receptor-mediated arrhythmias and sudden cardiac death
por: Blayney, Lynda M., et al.
Publicado: (2009)

Arrhythmias and sudden cardiac death in the COVID-19 pandemic
por: Kuck, Karl-Heinz
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_evdnv4thnetrd7t1fluinarinl